Tirzepatide

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Tirzepatide: Use in Patients With Hypothyroidism or Hyperthyroidism

Tirzepatide has not been studied in patients with hypothyroidism or hyperthyroidism.

US_cFAQ_TZP028_HYPOTHYROIDISM_HYPERTHYROIDISM
cFAQ
cFAQ
US_cFAQ_TZP028_HYPOTHYROIDISM_HYPERTHYROIDISM
en-US

Detailed Information

There is no information on the use of tirzepatide in people with hypothyroidism or hyperthyroidism because this has not been studied. People with controlled endocrine abnormalities were not excluded from tirzepatide clinical trials. However, patients were excluded if they had a significant, uncontrolled endocrine abnormality (for example, thyrotoxicosis or adrenal crises) in the opinion of the investigator.

Date of Last Review: February 05, 2021


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical